Expression of c-kit Receptor (CD 117) and CD34 in Leukemic Cells

References

• Schlossman S. F., Boumsell W. G., Harlan J. M., Kishimoto T., Morimoto C., Ritz J., Shaw S., Silverstein R. L., Springer T. A., Tedder T. F., Todd R. F. CD antigens 1993. Blood 1994; 83: 879–880
   PubMed Web of Science ®Google Scholar
• Zesbo K. M., Williams D. A., Geissler E. N., Broudy V. C., Martin F. H., Atkins H. L., Hsu R. Y., Birkett N. C., Okino K. H., Murdock D. C., Jacobsen F. W., Langley K. E., Smith K. A., Takeishi T., Cattanach B. M., Galli S. J., Suggs S. V. Stem cell factor is encoded at the S1 locus of the mouse and is the ligand for c-kit tyrosine kinase receptor. Cell 1990; 63: 213–224
   PubMed Web of Science ®Google Scholar
• Natali P. G., Nicotra M. R., Sures I., Santoro E., Bigotti A., Ulrich A. Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. Cancer Res. 1992; 52: 6139–6143
   PubMed Web of Science ®Google Scholar
• Ashman L. R., Cambareri A. C., Bik To L., Levinsky R. J., Juttner A. Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood 1991; 78: 30–37
   PubMed Web of Science ®Google Scholar
• Papayannopoulou T., Brice M., Broudy V. C., Zsebo M. Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: functional properties and composite antigenic profile. Blood 1991; 78: 1403–1412
   PubMed Web of Science ®Google Scholar
• Briddell R. A., Broudy V. C., Bruno E., Brandt J. E., Srour E. F., Hoffman R. Further phenotypic characterization and isolation of human hematopoietic progenitor cells using a monoclonal antibody to the c-kit receptor. Blood 1992; 79: 3159–3167
   PubMed Web of Science ®Google Scholar
• Broudy V. C., Lin N., Zsebo K. M., Birkett N. C., Smith K. A., Bernstein I. D., Papayannopoulou T. Isolation and Characterization of a monoclonal antibody that recognizes the human c-kit receptor. Blood 1992; 79: 338–346
   Google Scholar
• Brandt J., Briddell R. A., Srour E. F., Leemhuis T. B., Hoffman R. Role of c-kit ligand in the expansion of human hematopoietic progenitor cells. Blood 1992; 79: 634–641
   PubMed Web of Science ®Google Scholar
• Gadd S. J., Ashman L. K. A murine monoclonal antibody specific for a cell-surface antigen expressed by a subgroup of human myeloid leukaemias. Leuk. Res. 1985; 9: 1329–1336
   PubMed Web of Science ®Google Scholar
• Ashman L. K., Roberts M. M., Gadd S. J., Cooper S. J., Juttner C. A. Expression of a 150-kd cell surface antigen identified by monoclonal antibody YB5.B8 is associated with poor prognosis in acute non-lymphoblastic leukaemia. Leuk. Res. 1988; 12: 923–928
   PubMed Web of Science ®Google Scholar
• Wang C., Curtis J. E., Geissler E. N., McCulloch E. A., Minden M. D. The expression of the proto-oncogene c-kit in the blast cells of acute myeloid leukemia. Leukemia 1989; 3: 699–702
   PubMed Web of Science ®Google Scholar
• Dceda H., Kanakura Y., Tamaki T., Kuriu A., Kitayama H., Ishikawa J., Kanayama Y., Yonezawa T., Tarui S., Griffin J. D. Expression and functional role of the proto-oncogene c-kit in acute myeloblast c leukemia cells. Blood 1991; 78: 2962–2968
   PubMed Web of Science ®Google Scholar
• Bühring H. J., Ullrich A., Schaudt K., Müller C. A., Busch F. W. The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells. Leukemia 1991; 5: 854–860
   PubMed Web of Science ®Google Scholar
• Broudy V. C., Smith F. O., Lin N., Zsebo K. M., Egrie J., Bernstein I. D. Blasts from patients with acute myelogeneous leukemia express functional receptors for stem cell factor. Blood 1992; 80: 60–67
   PubMed Web of Science ®Google Scholar
• Ferrari S., Grande A., Zucchini P., Manfredini R., Tagliafico E., Rossi E., Temperani P., Torelli G., Emilia G., Torelli U. Overexpression of c-kit in a leukemic cell population carrying a trisomy 4 and its relationship with the proliferative capacity. Leukemia and Lymphoma 1993; 9: 495–501
   PubMed Web of Science ®Google Scholar
• Kanakura Y., Ikeda H., Kitayama H., Sugahara H., Furitsu T. Expression, function and activation of the proto-oncogene c-kit product in human leukemia cells. Leukemia and Lymphoma 1993; 10: 35–41
   PubMed Web of Science ®Google Scholar
• Muroi K., Amemiya Y., Miura Y., Nakamura M., Suda T. Role of c-kit receptor in the diagnosis of leukemia: a relationship between expression of c-kit and that of CD33 in leukemic blasts. Leuk. Res. 1993; 17: 725–726
   PubMed Web of Science ®Google Scholar
• Muroi K., Nakamura M., Amemiya Y., Suda T., Miura Y. Asynchronous expression of c-kit and CD34 on leukemic blasts. Br. J. Haematol. 1993; 85: 633–634
   PubMed Web of Science ®Google Scholar
• Reuss-Borit M. A., Buhring H. J., Schmidt H., Müller C. A. AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression. Leukemia 1994; 8: 258–263
   PubMed Web of Science ®Google Scholar
• Strauss L., Rowley S. D., La Russa V. F., Sharkis S. J., Stuart R. K., Civin C. I. Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. Exp. Hematol 1986; 14: 878–886
   PubMed Web of Science ®Google Scholar
• Terstappen L. W. M.M., Huang S., Safford M., Lansdorp P. M., Loken M. R. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. Blood 1991; 77: 1218–1227
   PubMed Web of Science ®Google Scholar
• Ema H., Suda T., Miura Y., Nakauchi H. Colony formation of clone-sorted human hematopoietic progenitors. Blood 1990; 75: 1941–1946
   PubMed Web of Science ®Google Scholar
• Greaves M. F., Brown J., Molggard H. V., Spun N. K., Robertson D., Delia D., Sutherland D. R. Molecular features of CD34: a hemopoietic progenitor cell-associated molecule. Leukemia 1992; 6(Suppl. 1)31–36
   PubMedGoogle Scholar
• Majdic O., Stockl J., Pickl W. F., Bohualav J., Strobl H., Scheinecker C., Stockinger H., Knapp W. Signal and induction of enhanced cytoadhesiveness via the hematopoietic progenitor cell surface molecule CD34. Blood 1994; 83: 1226–1234
   PubMed Web of Science ®Google Scholar
• Traweek T. Immunophenotypic analysis of acute leukemia. Am. J. Clin. Pathol. 1993; 99: 504–512
   PubMed Web of Science ®Google Scholar
• Silvestri F., Banavali S., Baccarani M., Preisler H. D. The CD34 hemopoietic progenitor cell associated antigen: biology and clinical applications. Hematologica 1992; 77: 265–272
   PubMed Web of Science ®Google Scholar
• Geller R. B., Zahurak M., Hurwitz C. A., Burker P. J., Karp J. E. Prognostic importance of immunophenotyping on adults with acute myelocytic leukemia: the significance of the stem-cell glycoprotein CD34 (My 10). Br. J. Haematol. 1990; 76: 340–347
   PubMed Web of Science ®Google Scholar
• Bennet J. M., Catovsky D., Daniel M.-T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). Br. J. Haematol. 1991; 78: 325–329
   PubMed Web of Science ®Google Scholar
• First M IC, Cooperative Study Group. Morphologic, immunologic, and cytogenetic (MIC) working classification of acute lymphoblastic leukemias. Cancer Genet. Cytogenet. 1986; 23: 189–197
   PubMedGoogle Scholar
• McNiece I. K., Langley K. E., Zsebo K. M. Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and Epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp. Hematol. 1991; 19: 226–231
   PubMed Web of Science ®Google Scholar
• A Cardoso M. L. L., Sansilvestri P., Hatzfeld A., Kisselev S., Batard P., Levesque J. P., Hatzfeld J. Co-stimulatory effects of steel factor, the c-kit ligand, on purified human hematopoietic progenitors in low cell density culture. Nouv. Rev. Fr. Hematol. 1993; 35: 81–86
   PubMedGoogle Scholar
• Dai C. H., Frantz S. B., Zsebo K. M. Human burst-forming units-erythroid need direct interaction with stem cell factor for further development. Blood 1991; 78: 2493–2497
   PubMed Web of Science ®Google Scholar
• Imai T., Nakahata T. Stem cell factor promotes proliferation human primitive megakaryocytic progenitors, but not megakaryocytic maturation. Int. Natl. J. Hematol. 1994; 59: 91–98
   PubMed Web of Science ®Google Scholar
• McNiece K., Langley K. E., Zsebo K. M. The role of recombinant stem cell factor in early B cell development. J. Immunol. 1991; 146: 3785–3790
   PubMed Web of Science ®Google Scholar
• Matsuzaki Y., Gyotoku J., Ogawa M., Nishikawa S., Katsura Y., Gachelin G., Nakauchi H. Characterization of c-kit positive intrathymic stem cells that are restricted to lymphoid differentiation. J. Exp. Med. 1993; 178: 1283–1292
   PubMed Web of Science ®Google Scholar
• Strobl H., Takimoto M., Majdic O., Hocker P., Knapp W. Antigenic analysis of human haemopoietic progenitor cells expressing the growth factor receptor c-kit. Br. J. Haematol. 1992; 82: 287–294
   PubMed Web of Science ®Google Scholar
• Loken M. P., Shah V. O., Dattilio K. L., Civin C. I. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 1987; 70: 1316–1324
   PubMed Web of Science ®Google Scholar
• Gore S. D., Kastan M. B., Civin C. I. Normal human bone marrow precursors that express terminal deoxynucleotidyl transferase include T-cell precursors and possible lymphoid stem cells. Blood 1991; 77: 1681–1690
   PubMed Web of Science ®Google Scholar
• Matos M. E., Schnier G. S., Becher M. S., Ashman L. K., Williams D. E., Caligiuri M. A. Expression of a functional c-kit receptor on a subset of natural killer cells. J. Exp. Med. 1993; 178: 1079–1084
   PubMed Web of Science ®Google Scholar
• Berenson R., Bensinger W. I., Hill R. S., Andrew R. G., Garcia-LLopez J., Kalamasz D. F., Still B. T., Spitzer G., Buckner C. D., Bernstein I. D., Thomas E. D. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 1991; 77: 1717–1722
   PubMed Web of Science ®Google Scholar
• Shpall E. J., Jones R. J., Bearman S. I., Franklin W. A., Archer P. G., Curiel T., Bitter M., Claman H. N., Stemmer S. ML, Purdy M., Myers S., Hami L., Taffs S., Heimfeld S., Hallagan J., Berenson R. J. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J. Clin. Oncol. 1994; 12: 28–36
   PubMed Web of Science ®Google Scholar
• Baum I. L., Weissman C. M., Tsukamoto A. S., Buckle A.-M., Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc. Natl. Acad. Sci. USA 1992; 89: 2804–2808
   PubMed Web of Science ®Google Scholar
• Gunji Y., Nakamura M., Osawa H., Nagayoshi K., Na-Kauchi H., Miura Y., Yanagisawa M., Suda T. Human primitive hematopoietic progenitor cells are more enriched in KITlow cells than in KIThigh cells. Blood 1993; 82: 3283–3289
   PubMed Web of Science ®Google Scholar
• Lerner N. B., Nocka K. H., Cole S. R., Qiu F., Strife A., Ashman L. K., Besmer P. Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 1991; 77: 1876–1883
   PubMed Web of Science ®Google Scholar
• Crosier I. S., Ricciardi S. T., Hall L. R., Vitas M. R., Clark S. C., Croisier K. E. Expression of iso-forms of the human receptor tyrosine kinase c-kit in leukemic cell lones and acute myeloid leukemia. Blood 1993; 82: 1151–1158
   PubMed Web of Science ®Google Scholar
• Nishii K., Kita H., Kawakami K., Nakase K., Masahiro M., Morita N., Omay S. B., Otsuji N., Fukumoto M., Shirakawa S. c-kit gene expression in CD7-positive acute lymphoblastic leukemia: close correlation with expression of myeloid-associated antigen CD13. Leukemia 1992; 6: 662–668
   PubMed Web of Science ®Google Scholar
• Compana D., Hansen-Hagge T. E., Matutes E., Coustan-Smith E., Shetty S., Yokota V., Bartram C. R., Janossy G. Phenotypic, genotypic, cytochemical and ultrastructural characterization of acute undifferentiated leukemia. Leukemia 1990; 4: 620–624
   PubMed Web of Science ®Google Scholar
• Brito-Babapulle F., Pullon H., Layton D. M., Etches A., Huxtablle A., Mangi M., Bellingham A. J. Clinicopathologic feature of acute undifferentiated leukemia with a stem cell phenotype. Br. J. Haematol. 1990; 76: 210–221
   PubMed Web of Science ®Google Scholar
• Travis W. D., Li C. Y., Bergstralh E. J., Yam L. T., Swee R. G. Mast cell leukemia: report of a case and review of the literature. Mayo Clinic Proceedings 1986; 61: 957–966
   PubMed Web of Science ®Google Scholar
• Terstappen L. W. M.M., Safford M., Konemann S., Loken M. R., Zurlutter K., Buchner T., Hiddemann W., Wörmann B. Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis. Leukemia 1991; 5: 757–767
   Web of Science ®Google Scholar
• Mirro J., Zipt T. F., Pui C. H., Kitchingman G., Williams D., Melvin S., Murphy S. B., Stass S. Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance. Blood 1985; 66: 1115–1123
   PubMed Web of Science ®Google Scholar
• Buccheri V., Matutes E., Dyer M. J. S., Catovsky D. Lineage commitment in biphenotypic acute leukemia. Leukemia 1993; 7: 919–927
   PubMed Web of Science ®Google Scholar